Dergiler / Turkish Journal of Medical Sciences / 2017 / Cilt: 47 - Sayı: 2

Profile of POT1 as telomerase shelterin component discriminates between cervical cancer and normal cervical cells

Sayfa
417–423
Yayın Tarihi
2022-11-05
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The high level of POT1 in the biopsy tissue of cervical cancer patients showed the influence of this shelterin component in cervical carcinogenesis and also cell immortalization.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background/aim: Telomerase activity is influenced by hTERT transcriptional regulation, shelterin, and posttranscriptional alternative splicing.
📊
Temel Bulgular & Veri:Telomerase shelterin such as POT1 is highly correlated with various cancers.
💡
Sonuç & Katkı:The high level of POT1 in the biopsy tissue of cervical cancer patients showed the influence of this shelterin component in cervical carcinogenesis and also cell immortalization.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Background/aim: Telomerase activity is influenced by hTERT transcriptional regulation, shelterin, and posttranscriptional alternative splicing. Telomerase shelterin such as POT1 is highly correlated with various cancers. However, the profile of POT1 in cervical cancer has not been clearly identified. Therefore, it is important to identify its profile in cervical cancer biopsy tissue and normal cervical smears. Materials and methods: Biopsy tissue of cervical cancer patients and normal cervical smears were characterized using SDS-PAGE and western blot. Sixteen biopsy tissues of cervical cancer patients and 15 normal cervical smears were measured for POT1 level using ELISA. Results: The inline band at 70 kDa indicated that all samples had protein that was identified as POT1. Western blot showed that telomerase antibody only recognized POT1 in biopsy tissue of cervical cancer patients. There was a significant difference (P = 0.01) in POT1 level between biopsy tissue of cervical cancer patients and normal cervical smears. Conclusion: POT1 was identified at 70 kDa in biopsy tissue of cervical cancer patients and its level was higher than that in normal cervical smears. The high level of POT1 in the biopsy tissue of cervical cancer patients showed the influence of this shelterin component in cervical carcinogenesis and also cell immortalization.

🔖

Bu Makaleye Atıf Yap

WIJAYA, A. B., HIDAYATULLAH, F., SETYABUDHI, V. V., PAHLEVI, F. R., INDRA, R., NURSETA, T. (2022). Profile of POT1 as telomerase shelterin component discriminates between cervical cancer and normal cervical cells. Turkish Journal of Medical Sciences, Cilt: 47 - Sayı: 2, 417–423. https://ajindex.com/articles/610614

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Fact Sheet: Genital HPV; 2010
  2. Forouzanfar MH, Lozano R, Lopez AD, Delossantos AM, Foreman KJ, Murray CJ. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet 2011; 378: 1461-1484
  3. Catarino R, Araújo A, Coelho A, Gomes M, Nogueira A, Lopes C, Medeiros RM. Prognostic significance of telomerase polymorphism in non-small cell lung cancer. Clinical Cancer Research 2010; 16: 3706-3712
  4. Artandi SE, De Pinho RA. Telomeres and telomerase in cancer. Carcinogenesis 2010; 31: 9-18
  5. Zhen WS, Heng SJ, Wei Z, Qian JS, Ping WH, Sheng JY, Ping Q, Yi L, Mo L. Telomerase activity in cervical intraepithelial neoplasia. Chinese Medical Journal 2004; 117: 202-206
  6. Liddell, JE. Antibody Purification by Ammonium Sulfate Precipitation. University of Cardiff; 2003
  7. Wojtyla A, Gladych M, Rubis B. Human telomerase activity regulation. Mol Biol Rep 2011; 38: 3339-3349
  8. Ponsot E, Laguna AE, Delis AM, Kadi F. Telomere length and regulatory proteins in human skeletal muscle with and without ongoing regenerative cycles. Exp Physiol 2012; 55: 21-28
  9. Wanga F, Tanga M, Zeng Z, Wua R, Xue Y, Hao Y, Pang D, Zhao Y, Tana Z. Telomere- and telomerase-interacting protein that unfolds telomere G-quadruplex and promotes telomere extension in mammalian cells. Biochemistry 2012, PNAS Early Edition: 1-6
  10. Xin H, Liu D, Wan M, Safari A, Kim H, Sun W, O’Connor MS, Songyang Z. TPP1 is a homologue of ciliate TEBP-beta and interacts with POT1 to recruit telomerase. Nature 2007; 445: 559-562
  11. Wang F, Podell ER, Zaug AJ, Yang Y, Baciu P, Cech TR, Lei M. The POT1-TPP1 telomere complex is a telomerase processivity factor. Nature 2007; 445: 506-510
  12. Liu F, Pu XY, Xiang GM, Jiang DN, Hou G, Huang DN. Expression of hPOT1 in HeLa cells and the probability of gene variation of hpot1 Exon14 in endometrial cancer are much higher than in other cancers. Asian Pacific J Cancer Prev 2012, 13: 5659-5663
  13. Fujii K, Sasahira T, Moriwaka Y. Protection of telomeres 1 protein levels are associated with telomere length in gastric cancer. Int J Mol Med 2008; 5: 599-604
  14. Wan SM, Tie J, Zhang YF. Silencing of the hPOT1 gene by RNA inference promotes apoptosis and inhibits proliferation and aggressive phenotype of gastric cancer cells, likely through upregulating PinX1 expression. J Clin Pathol 2011; 12: 1051-1057
  15. Tang T, Zhou FX, Lei H. Increased expression of telomere